This Government Contract opportunity from Department Of Defense was posted on September 23, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Blood Gas Analyzers for Department of Pathology, TAMC

Awarded

W81K0225QA058Federal

Submission Closed09/22/2025, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

DIBBS

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-1071

Solicitation SPE2DS-27-T-1071, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2-30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of the order, with a final delivery date of October 30, 2026, to the USS IDAHO (SSN 799). The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires labels to include the contract or lot number and the date of manufacture, expiration, or retest. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area Workflow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, the Buy American Act, and the prohibition of covered defense telecommunications equipment. Quotations are due by November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CULTURE MEDIUM, THAYER-

Solicitation # SPE2DS-27-T-1066

Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of ALBAcyte Blood Bank ReagentsThis subcontract involves the manufacture and supply of specialized ALBAcyte blood bank reagents for prime contractors supporting the Department of Veterans Affairs North Texas Health Care System. The scope of work includes the delivery of A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated RBCs. To ensure product efficacy, the contractor must utilize shipping containers that maintain reagent integrity and adhere to a defined Quality Plan and FDA approval standards. Deliveries are to be made FOB Destination to the Transfusion Medicine Unit located in Dallas, Texas. The contract is categorized under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 17.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6550--Blood Bank Reagents

Solicitation # 36C25727Q0065

The Department of Veterans Affairs VA North Texas Health Care System is issuing a Sources Sought Notice to identify qualified vendors capable of providing blood bank reagents for the Transfusion Medicine Unit in Dallas, Texas. These reagents, including ALBAcyte A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated Red Blood Cells, are essential for manual blood typing and serum antibody detection used in cross-matching blood for transfusions. The anticipated acquisition strategy includes a base year starting May 1, 2027, with four subsequent one-year option periods extending through April 30, 2032. To be considered, vendors must be FDA approved, provide documentation of such approval, and maintain a defined quality plan with adequate supply availability. All shipments must be FOB Destination, and the contractor is responsible for providing appropriate shipping containers. Interested vendors must submit an electronic capability statement in PDF or Word format, including the place of manufacture for all listed reagents, to the designated contract specialist by November 5, 2026, at 9:00 AM CST. This notice is for market research purposes only to determine the appropriate acquisition strategy, such as a small business set-aside, and does not constitute a formal solicitation.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6505--DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)

Solicitation # 36C77027Q0015

The Department of Veterans Affairs, National CMOP Office, is conducting market research through a Sources Sought announcement to identify qualified sources for the procurement of Drawtex Dressing, 4in X 4in, packaged as 10ct per box. This action is for market research purposes only and is not a formal solicitation for quotes; therefore, no contract will be awarded based on this specific announcement. The place of performance is located in Ladson, South Carolina, and the primary point of contact is Contract Specialist Claudine Challinor. Interested respondents must submit their information via email by November 3, 2026. Required details include the company's SAM Unique ID Number, business size (Small, Large, SDVOSB, or VOSB), and point of contact information. Specifically, the government is seeking to determine if the respondent is the manufacturer, the manufacturer's product number, and the place of manufacturing. If the respondent is not the manufacturer, they must provide a letter of authorization from the original equipment manufacturer or provide detailed product literature and specifications for alternative products that demonstrate similarities to the Drawtex hydro conductive wound dressing.

National Cmop Office (36C770)

POSTED

DEADLINE

6550--Optilite analyzer reagents

Solicitation # 36C26227Q0052

The Department of Veterans Affairs, Southern Arizona Healthcare System, is soliciting a Firm-Fixed Price Blanket Purchase Agreement under solicitation 36C26227Q0052 for the procurement of FDA-approved reference testing reagents and consumables validated for use on the Optilite analyzer. The scope includes specific items such as Freelite Kappa, Freelite Lambda, and Ceruloplasmin reagents, as well as TENCELL cuvettes and sample cups. To ensure system performance and safety, all materials must be manufactured by Binding Site Laboratories, and substitutions are prohibited. The contract is issued as a full and open competition under NAICS code 325413, with a total estimated period of performance of sixty months, consisting of a base period from November 9, 2026, to November 8, 2027, followed by four one-year option periods. The award will be granted to the responsible offeror whose proposal is most advantageous to the government, based on a technical acceptability review of the Statement of Work and the lowest price. Deliveries are required to be made to various VA Medical Centers across Arizona, California, and New Mexico, with standard orders delivered within four working days of placement. All shipments must be destination-based, with the vendor assuming all shipping costs and adhering to strict packaging standards to prevent damage. Invoicing is handled electronically through the Department of Veterans Affairs Financial Services Center in accordance with the Prompt Payment Act. Quotes must be submitted via email to Contract Specialist Carlos Magana by November 4, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Supply of i-STAT PT Plus Control Reagent Level 1This subcontract involves the procurement and delivery of i-STAT PT Plus Control Reagent Level 1 for coagulation testing to support prime contractors fulfilling Department of Defense supply contracts. The scope of work requires the delivery of two boxes, each containing ten 1.0 mL units, shipped FOB Destination to a performance location in APO 96260-5479. To ensure quality and safety, all supplied reagents must adhere to Regulation 864.7750 Class II requirements and maintain full compliance with Registration, Listing, Labeling, and Good Manufacturing Practices. This requirement is managed under NAICS code 325413 for the Medical Supply Chain MD Surg FSF agency.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL SET, BLOOD CHEM

Solicitation # SPE2DS-27-T-0906

Solicitation SPE2DS-27-T-0906 is a request for quotations from DLA Troop Support for two sets of DXH 500 Series Blood Chemistry Control (NSN 6550-01-688-9090). This assayed whole blood control is used to monitor multi-parameter hematology cell counters and includes abnormal low, normal, and abnormal high components. The items must be stored refrigerated and upright between 2 to 8 degrees Celsius and protected from freezing and overheating. Delivery is required within 20 days after receipt of order, with a required delivery date of October 27, 2026, under FOB Destination terms. The contract imposes strict shelf-life requirements, specifying a non-extendable shelf life of 3 months, with no more than 13 days elapsed from the date of manufacture to the date of delivery. Packaging must be commercial and compliant with RP001 and MIL-STD-2073-1E, while marking must adhere to Medical Marking Standard No. 1. Invoicing is to be processed electronically via the Wide Area Workflow system. This is not a small business set-aside, and the procurement falls under NAICS code 325413. Compliance with the Buy American and Balance of Payments Program and DFARS safeguarding of covered defense information is required.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-27-T-0950

Solicitation SPE2DS-27-T-0950 is a Request for Quotations issued by the Department of Defense, DLA Troop Support Medical Supply Chain, for the procurement of two boxes of i-STAT PT Plus Control Reagent Level 1 (NSN 6550-01-728-5703). This reagent is used for coagulation testing and is compatible with the i-STAT PT Plus cartridge and the i-STAT 1 Government Field Kit analyzer. Each box contains ten 1.0 mL units. The required delivery date is October 23, 2026, with a delivery window of 83 days after award. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contract mandates strict quality and storage requirements, including refrigeration between 2 to 8 degrees Celsius and a non-extendable shelf life of 12 months. Items must be delivered within one month of the manufacture date. Packaging must be commercial and adhere to MIL-STD-2073-1E and RP001, with marking compliant with Medical Marking Standard No. 1. Labels must include the contract/lot number and manufacture or expiration dates. The procurement is not a small business set-aside, though a HUBZone price evaluation preference may be applied. Compliance with the Buy American Act and DFARS domestic material restrictions is required, and electronic invoicing must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems

Solicitation # HT942627QE003

The Defense Health Agency is soliciting quotations to establish a Blanket Purchase Agreement (BPA) for the recurring resupply of consumable products for three Terumo Trima Accel Blood Collection Systems used by the USAISR Combat Casualty Care Research Team 1 in Texas. To maintain FDA approval and satisfy research protocols, the contractor must provide original manufacturer-supplied consumables, including Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD Wafers, ACD-A Solution, and 150 mL couplers. This procurement is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses under NAICS 325413. The resulting BPA will have a 60-month ordering period with a total ceiling of 35 million dollars, though some documentation notes a lower limit of 350,000 dollars. Individual call orders are capped at 50,000 dollars, while Government Purchase Card orders are limited to 15,000 dollars. Awards will be made on a Lowest Price Technically Acceptable basis, with technical capability rated as pass or fail. All payment requests and receiving reports must be processed electronically through the Wide Area WorkFlow system. Quotations are due by November 6, 2026, and must be submitted in two separate volumes covering technical capability and pricing.

Army Medical Resources Acq Activity

POSTED

DEADLINE

Custom ArcherDX VariantPlex NGS Target-Enrichment KitsThis subcontract involves the supply of custom-designed Next-Generation Sequencing target-enrichment library preparation kits to support prime contractors on NIH NHLBI projects. The required kits must be manufactured using proprietary ArcherDX VariantPlex Anchored Multiplex PCR chemistry and pre-amplification ligation of unique molecular barcodes. To ensure operational compatibility, all delivered kits must function with Archer Analysis software and Illumina NovaSeq instruments. Managed under the National Institutes of Health Olao within the Department of Health and Human Services, the contract falls under NAICS code 325413. The procurement process began with a posting date of October 22, 2026, and established a response deadline of November 2, 2026.

National Institutes Of Health Olao

POSTED

DEADLINE

6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ

Solicitation # 36C24527Q0042

The Department of Veterans Affairs, specifically the VA North Atlantic Health Network (HSA 1.3), is soliciting a firm-fixed-price, Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Cepheid GeneXpert testing supplies. This requirement covers the procurement of FDA-approved reagents, consumables, and service for PCR analyzers to detect various pathogens, including CoV-2, Influenza, RSV, MRSA, and Mycobacterium Tuberculosis. The contract is structured with a base period ending October 31, 2027, and three subsequent one-year option periods extending through October 31, 2030. Deliveries will be made to multiple VA Medical Centers across Maryland, West Virginia, and Washington DC. This acquisition is set aside for HUBZone small businesses. Award will be determined using the Lowest Price Technically Acceptable (LPTA) method, evaluating technical acceptability, delivery performance, past performance, and price, with additional credit given to certified SDVOSB or VOSB offerors. Key contractor requirements include being an authorized distributor, acknowledging orders within 24 hours, and guaranteeing a minimum four-month expiration date on reagents. Additionally, the vendor must provide an emergency plan to deliver replacement supplies within 24 hours if products are found to be defective. Invoices must be submitted electronically, and payments will be processed in accordance with the Prompt Payment Act.

245-NETWORK Contract Office 5 (36C245)

POSTED

7 days ago

DEADLINE

in 7 days

AI Contract Overview

The Medical Readiness Contracting Office - Pacific is soliciting proposals under solicitation number W81K0225QA058 for the procurement of blood gas analyzers and associated reagents for the Department of Pathology at Tripler Army Medical Center in Hawaii. This unrestricted procurement, categorized under NAICS code 325413, seeks a firm fixed-price purchase order consisting of a base period and four option periods. The scope of work includes the provision of analyzers that meet specific technical, operational, and data management salient characteristics, as well as the supply of reagent cartridges, quality control materials, calibration supplies, and maintenance consumables. Successful offerors must comply with rigorous regulatory and security standards, including DHA Cyber Logistics Risk Management Framework requirements for cybersecurity and FedRAMP approval for cloud services. Additionally, contractors must adhere to strict guidelines regarding the handling of Protected Health Information and Personally Identifiable Information in compliance with HIPAA and the Privacy Act. Proposals must be submitted by September 15, 2025, and must include completed offeror representations and certifications. All vendors must be registered in the System for Award Management to be eligible for the award.

General Info

Agency

Department Of Defense → W40M Mrco Pacific

Contract Value

$366,171.8

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Tripler Army Medical Center, HI, USA

Set-Aside

NONE

Awardee

SIEMENS HEALTHCARE DIAGNOSTICS INC. Tarrytown NY 10591 USA

Award Issued Date

09/22/2025, 12:00:00 AM UTC

Documents

Attachment 2: Additional Instructions & Information

specifications

High

DHA Cyber Logistics RMF Requirements v1.4 (Attachment 4)

sow

High

Salient Characteristics for Blood Gas Analyzers - Tripler Army Medical Center

sow

High

W81K0225QA058 - Supplies and Prices/Costs

rfq

High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded

PostedMay 19

Sources Sought

Type ChangedAug 15

Sources Sought → Combined Synopsis

AwardedSep 22

Contract was awarded

Submission Closed

09/22/2025, 12:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → W40M Mrco Pacific

Contacts1 person available

OfficeFORT SHAFTER, HI, 96858-5098, USA

Organization / AgencyDepartment Of Defense → W40M Mrco Pacific

Office AddressFORT SHAFTER, HI, 96858-5098, USA

Contacts

Keary Haubner

contact@example.gov

+1 (555) 000-0000

Full Description

Sources Sought for W81K0225QA058 Blood Gas Analyzers and Regents for the Dept. of Pathology & Area Laboratory Services at Tripler Army Medical Center, HI. This is a Sources Sought Notice for Tripler Army Medical Center. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of qualified sources and whether or not to conduct this procurement on a competitive basis. The NAICS code is 325413 and the successful vendor must be registered in SAM.gov with this NAICS. Responses to the information requested will assist the Government in determining the appropriate set-aside and acquisition method. The Medical Readiness Contracting Office - Pacific intends to award a Firm, Fixed-Price order for a base period with up to four (4) option periods to the successful offeror using FAR Parts 12 procedures. The requirement is for a firm fixed price contract based on the following Salient Characteristics: Blood Gas Analyzers (BGA) shall provide the following analytes in one full test menu that can be executed all at once: pH, pO2, pCO2, Na+, K+, ionized calcium, Cl-, glucose, lactate, hemoglobin, total hemoglobin, hematocrit, BUN, Creatinine, SO2, O2Hb, HHb, COHb, MetHb. The BGA test menus, while providing the full test menu (pH, pO2, pCO2, Na+, K+, ionized calcium, Cl-, glucose, lactate, hemoglobin, total hemoglobin, hematocrit, BUN, Creatinine, SO2, O2Hb, HHb, COHb, MetHb) shall be customizable. The BGA shall have an on-board clot detector that detects clots before causing the instrument to become inoperable. The BGA vendor shall provide technical and software support 24 hours 7 days a week including holidays and shall have on-island service support. The BGA shall NOT require gas tanks and bottled reagents. Analyzer shall be mobile or considered benchtop. The total dimensions of the analyzer including any storage shall not exceed: Width - 2 feet, 2 feet, 3 feet. The BGA shall have mobile capability, be lightweight (no more than 30 pounds) and fit securely, with its UPS (uninterrupted power supply) in a tip-proof cart. The BGA shall have a complete data manager system capability to actively track number of patients tested, number of valid QC results, number of proficiencies and offline training for competencies evaluation. The BGA shall have its own data management system or be compatible with a data management system that is compatible with MHS Genesis and can actively manipulate multiple instruments, monitoring real-time system status, and sequester statistical data from a centralized location. The BGA shall have a centralized data manager workstation capable of allowing a supervisor or QA to manipulate all analyzers for user lockouts, alerts, maintenance, forcing QC and Calibration. The BGA shall have configurable/customizable system alert screen that signals sample condition, device warnings, operator certification, etc. The BGA shall have a large peer group comparison for CAP Survey material. CAP is the accrediting agency for the laboratory. The BGA shall have an automatic onboard quality control and calibration. This shall be done automatically requiring no operator intervention. The BGA shall require no reagent preparation, reagents and calibrators are ready to use. Instrument shall have automated maintenance, calibrators, and QC that requires no or minimum tech's hands-on, or vendor must perform quarterly maintenance. The BGA shall be FDA approved and accept the following sample types: arterial, venous, capillary, pleural fluid, and mix-venous. The BGA shall have the ability to test pH of pleural fluid. The BGA shall possess an onboard event log. Analyzer shall have the ability to have built-in QC and calibrators with auto QC and calibrators run. The BGA shall be able to execute the full test menu (pH, pO2, pCO2, Na+, K+, ionized calcium, Cl-, glucose, lactate, hemoglobin, total hemoglobin, hematocrit, BUN, Creatinine, SO2, O2Hb, HHb, COHb, MetHb) in 120 seconds or less. The BGA shall be able to execute the full test menu (pH, pO2, pCO2, Na+, K+, ionized calcium, Cl-, glucose, lactate, hemoglobin, total hemoglobin, hematocrit, BUN, Creatinine, SO2, O2Hb, HHb, COHb, MetHb) with a sample size no larger than 150 microliters. The BGA shall be able to accept specimens from a capillary tube, test tube or syringe at a single port. The BGA shall be able to stop or interrupt QC and calibration operations to allow testing of STAT specimens. The BGA shall have sample aspiration that is automated and consistent to eliminate variability in sample technique among operators. The BGA shall have self-cleaning probe. The BGA shall have a specimen identification with an integrated barcode reader that shall read current patient ID labels and have individual log in credentials. The BGA shall have training and trouble-shooting modules on-board. The BGA shall have the ability to physically print patient results with all required demographic data when connection to the Laboratory Information System in inoperable. The BGA shall have the ability for the TAMC staff to limit operators to only those who have been trained. The BGA shall have QC lockout ability, that is, if QC is not run or fails, the instrument will not test a patient specimen. The BGA shall have a contained waste collection system in order reduce exposure to biohazards and a disposal mechanism that requires no more than a few minutes to complete. The BGA shall provide associated calculated results automatically, in addition to measured results. The BGA shall allow for entry of FiO2 and temperature and calculates corrected results for pH, pCO2 and pO2 automatically. The Vendor shall be responsible for any IT related cost e.g. Authorization to Operate (ATO). Installation validation shall be completed by the vendor according to College of American Pathologists standards. Validation shall include whole blood, and different body fluids. Initial instrument training shall be provided by the vendor. Interested vendors may submit in writing their capabilities and qualifications demonstrating their ability to fulfill the requirement identified in this notice. Responses to this notice should include company name, address, and telephone number, point of contact (POC), and brochures which will allow the Government to understand your offerings and options. Capability statements should be submitted to the attention of Mr. Keary Haubner, Contract Specialist, email contact@example.gov. Telephone responses will not be accepted. Responses must be received no later than 2 June 2025 at 2:00 PM Hawaii Standard Time. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required items. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response. A determination by the government not to compete this proposed effort on a full and open competition basis, based upon responses to this notice, is solely within the discretion of the government.